Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of tPA in Intra-abdominal Abscesses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Intrabdominal abscess~Exclusion Criteria:~* Hypersensitivity to tPA~* Recent stroke~* Uncontrolled htn~* Recent major hemorrhage~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Tissue Plasminogen Activator (Type: ACTIVE_COMPARATOR): tPA administered by drainage tube into abscess, allowed to dwell for one hour and then drained into drainage bag. Dose of tPA administered to be determined by the volume of drainage immediately post drain insertion. This intervention is done on day 0, 1 and 2.
- Instillation of Normal Saline (Type: SHAM_COMPARATOR): Insertion of abdominal drainage tube to drain intra-abdominal abscess. Normal Saline administered immediately post drain insertion. Normal Saline (10 cc) allowed to dwell for one hour, then allowed to drain into drainage bag.

Based on this trial design, predict the completion outcome and termination type (if applicable).